Stéphanie Fallot

Title: Stephanie Fallot: Innovator in Monoclonal Antibodies

Introduction

Stephanie Fallot is a prominent inventor based in Lyons, France. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her work focuses on therapeutic applications that have the potential to impact various medical conditions.

Latest Patents

Stephanie Fallot holds a patent for "Humanized, mouse or chimeric anti-CD47 monoclonal antibodies." This invention provides antibodies that bind to human glycosylated and deglycosylated CD47 with an optimized Koff value. These antibodies disrupt the human CD47-SIRPα interaction and find use in various therapeutic, preventive, or diagnostic methods. The patent includes isolated antibodies, derivatives, fragments, pharmaceutical formulations, and cell lines that produce these monoclonal antibodies. Additionally, it provides amino acid and nucleotide sequences of the antibodies.

Career Highlights

Stephanie is associated with Forty Seven, Inc., where she continues to advance her research and development efforts. Her innovative work in monoclonal antibodies has positioned her as a key figure in the biotechnology sector.

Collaborations

Stephanie collaborates with notable colleagues, including Marie Chalons-Cottavoz and Mehdi Lahmar. These partnerships enhance her research capabilities and contribute to the success of her projects.

Conclusion

Stephanie Fallot is a trailblazer in the field of monoclonal antibodies, with her patent showcasing her innovative spirit and dedication to advancing medical science. Her contributions are poised to make a lasting impact in therapeutic applications.